Participants 93 122 3
B-cell non-Hodgkin's lymphoma
Participants 435 471 4
patients with non-Hodgkin's lymphoma
Participants 473 577 4
Twenty seven patients were mobilized with etoposide and G-CSF and 28 with etoposide, G-CSF and rituximab
